Global paresthesia market is expected to grow at a substantial CAGR in the forecast period of 2020-2026. Paresthesia is a central nervous system (CNS) disorder characterized by an abnormal sensation to the skin such as tickling, tingling, pricking numbness or burning sensation with no apparent physical cause. The symptoms can become chronic as well. Diseases such as arthritis, diabetes and cancer enhance the cases of paresthesia.

Key Market Players:

The key market players in the global paresthesia market­ are AbbVie Inc, Johnson & Johnson Services, Inc, Takeda Pharmaceutical Company Limited, Baxter, Merck & Co., Inc, Novo Nordisk A/S, CELGENE CORPORATION, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Abbott Pfizer Inc, Novartis AG, Medtronic, Omron Healthcare, Inc, Boston Scientific Corporation, Stimwave LLC, Nevro Corp, Cyberonics, Inc, and others.

Get Free Sample Copy of Report Here: @

Segmentation: Global Paresthesia Market­

  • By Types (Acute Paresthesia, Chronic Paresthesia)
  • By Treatment (Immunosuppressant, Anticonvulsants, Tropical Creams, Antivirals, and Others)
  • By Distribution Channel (Online Pharmacy, Direct Tenders (Retailers and Others)
  • By Route of Administration (Oral, Topical, Intravenous and Others)
  • By End- Users (Hospitals, Homecare, Specialty Clinics, Others)

Competitive Analysis: Global Paresthesia Market

Global paresthesia market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of paresthesia market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Drivers

  • Increasing prevalence of diabetes, cancer, and other chronic diseases acts as a driver for the market growth
  • Excess smoking and alcohol consumption by the people will also drive the market growth
  • Development in the healthcare expenditure and the government support for the research & development for new and better treatment have fueled the market growth

Market Restraints

  • Strict regulatory rules and long drug approval time may hinder the market growth
  • Lack of effectiveness and unavailability of precise treatment can also restrict the growth of this market
  • Lack of awareness amongst people regarding paresthesia also hampers the market growth

Want Full Report? Enquire Here @   

Reasons to Purchase this Report

  • Current and future of global paresthesia market outlook in the developed and emerging markets.
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
  • The latest developments, market shares, and strategies that are employed by the major market players.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research

US: +1 888 387 2818   

Related Reports:

Thalassemia Market

Tinea Pedis Treatment Market